Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Is The Cardiac Biomarkers Testing Market Expected To Grow In Terms Of Size?

There has been a significant expansion in the market size of cardiac biomarkers testing in the recent past. Projected growth indicates that it will rise from $13.48 billion in 2024, reaching a value of $14.95 billion in 2025 with a compound annual growth rate (CAGR) of 10.9%. The notable growth observed in the historic period is linked to factors such as a surge in cardiovascular disorders, an increase in the aging population, heightened awareness and education campaigns, government-led initiatives and healthcare strategies, and a rise in healthcare spending.

Over the coming years, the market size for cardiac biomarkers testing is anticipated to experience swift expansion. By 2029, it is projected to grow to a worth of “$23.24 billion, with a compound annual growth rate (CAGR) of 11.7%. Contributing factors to this projected growth include a rise in personalized medicine, an increasing worldwide prevalence of cardiovascular diseases, the use of artificial intelligence in diagnostics, widening of point-of-care testing, and escalating emphasis on detecting diseases at an early stage. Key trends to watch during this forecast period encompass technological innovations, developments in AI-facilitated diagnostics, expansion of point-of-care testing (POCT), enhanced multiplexing capabilities, and advancements in biomarker identification and validation.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp

Which Demand Drivers Are Strengthening The Cardiac Biomarkers Testing Market?

The growth of the cardiac biomarkers testing market is anticipated to be propelled by the rising incidences of cardiovascular diseases. These diseases typically impact the heart or the blood vessels. Cardiac biomarker tests are crucial in identifying the levels of biomarkers for prompt assessment of the seriousness and scale of a heart attack. Consequently, a rise in cardiovascular diseases will result in higher demand for cardiac biomarker testing solutions. For example, projections from the American College of Cardiology, a professional medical entity based in the US, indicated in August 2022 that the rates of cardiovascular risk factors and disease are set to significantly increase in the United States by 2060. Hence, the increasing prevalence of cardiovascular diseases is spurring the growth of the cardiac biomarkers testing market.

What Is The Segment Breakdown Of The Cardiac Biomarkers Testing Market?

The cardiac biomarkers testing market covered in this report is segmented –

1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types

2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications

3) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass

2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)

3) By Myoglobin: Total Myoglobin

4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)

5) By Ischemia Modified Albumin (IMA): IMA Levels

6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2

How Are Global Trends Impacting The Development Of The Cardiac Biomarkers Testing Market?

Prominent companies in the cardiac biomarker testing market are forming strategic alliances to introduce technology for early detection of heart condition markers, thus improving patient prognosis. Such alliances in cardiac biomarker testing promote co-operation among businesses, paving way for innovative diagnostics, increasing market penetration, and speeding up the accessibility of advanced testing solutions for enhanced cardiac care. For instance, in September 2024, MediBuddy, an Indian healthcare tech firm offering an all-inclusive platform for telehealth services, health management, and insurance aid, formed an alliance with Philips, a conglomerate corporation based in Netherlands. The motive behind this partnership is to boost cardiac care in India by integrating Philips’ HeartPrint technology, enabling routine monitoring and evaluating risk factors of heart health. This progressive strategy equips users with superior tools on the MediBuddy platform, encouraging proactive management of cardiac health and improved outcomes.

Who Are The Leading Companies Driving The Cardiac Biomarkers Testing Market?

Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

Which Region Is Leading Innovation In The Cardiac Biomarkers Testing Market?

North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=9436&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model